BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Exelixis
Neonc Technologies, Inc.
Bristol-Myers Squibb
Aulos Bioscience, Inc.
Yale University
Mayo Clinic
Emory University
Iovance Biotherapeutics, Inc.
Gustave Roussy, Cancer Campus, Grand Paris
University of Pittsburgh